Normothermic ex vivo perfusion of isolated lungs in an experiment using a russian-made perfusion system

According to global health statistics, respiratory diseases, together with infectious complications and hereditary lung diseases, rank as the third leading cause of death. Today, lung transplantation (LTx) is a well-recognized modality of treatment for end-stage chronic lung disease. However, the number of LTx surgeries performed is much lower than other solid organs. This is due to the high requirements for the potential donor and characteristics of the lung graft, reflecting the efficiency of gas exchange function. Non-compliance with the selection criteria leads to deselection of donors, which, according to various estimates, occurs in 80–85% of cases. One of the ways to increase the number of lung transplant surgeries is to restore them to the level of optimal gas exchange parameters, which can be achieved and objectively assessed during normothermic ex vivo lung perfusion (EVLP). EVLP is becoming increasingly common at leading transplantation centers in Europe and North America. This has significantly increased the number of transplant surgeries as a result of using lungs procured from suboptimal donors and rehabilitated via EVLP. In our pilot study, the developed Russian-made mechanical circulatory support system showed that performing normothermic EVLP for isolated lungs under experimental conditions is feasible. Basic and optimized perfusion protocols have fully shown that they are reliable and efficient.

1. Chambers DC et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report – 2019; Focus theme: Donor and recipient size match. Journal of Heart and Lung Transplantation. 2019; 38 (10): 1042–1055.

2. Nelems JM et al. Human lung transplantation. Chest. 1980; 78 (4): 569–573.

3. Chakos A et al. Ex-vivo lung perfusion versus standard protocol lung transplantation-mid-term survival and meta-analysis. Annals of Cardiothoracic Surgery. 2020; 9 (1): 1–9.

4. Nilsson T. Ex vivo Lung Perfusion – Experimental and Clinical Studies. 2018: 88. ISBN 978-91-629-0467-8. https://gupea.ub.gu.se/handle/2077/55384.

5. Zoeller KA. Pulsatile flow does not improve efficacy in ex vivo / The University of Louisville s Institutional Repository – 2013.

6. Cypel M, Keshavjee S. Ex vivo Lung Perfusion. Operative Techniques in Thoracic and Cardiovascular Surgery. 2014; 19 (4): 433–442.

7. Gulyaev V, Zhuravel S, Novruzbekov M et al. Will the machine perfusion of the liver increase the number of donor organs suitable for transplantation? Transplantologiya. 2018; 10 (4): 308–326.

8. Raghu G, Carbone RG. Lung Transplantation: Evolving Knowledge and New Horizons. 2018: 370.

9. Mohan S et al. Factors leading to the discard of deceased donor kidneys in the United States. Kidney International. 2018; 94 (1): 187–198.

10. Mattar A, Chatterjee S, Loor G. Bridging to Lung Transplantation. Critical Care Clinics. 2019; 35 (1): 11–25.

11. Bunenkov NS, Komok VV, Grudinin NV et al. SAS Enterprise Guide 6.1: predstavlenie bazovyh harakteristik pacientov. Medicinskij akademicheskij zhurnal. 2021; 21 (1): 59–64. doi: 10.17816/MAJ64682.

12. Grudinin NV, Bogdanov VK, Sharapov MG et al. Use of peroxiredoxin for preconditioning of heterotopic heart transplantation in a rat. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (2): 158–164. https://doi.org/10.15825/1995-1191-2020-2-158-164.

13. Gautier SV, Tsirulnikova OM, Pashkov IV et al. Evaluation of the efficacy of a novel perfusion solution for normothermic ex vivo lung perfusion compared with Steen solution™ (animal experimental study). Russian Journal of Transplantology and Artificial Organs. 2021; 23(3): 82–89. https://doi.org/10.15825/1995-1191-2021-3-82-89.

14. Reed RM, Eberlein M. Sizing strategies in heart and lung transplantation: You cannot manage what you do not measure. Future Cardiology. 2014; 10 (3): 303–306.

15. Kotecha S et al. Continued Successful Evolution of Extended Criteria Donor Lungs for Transplantation. Annals of Thoracic Surgery. 2017; 104 (5): 1702–1709.

16. Lee HJ et al. Use of Extracorporeal Membrane Oxygenation Prior to Lung Transplantation Does Not Jeopardize Short-term Survival. Transplantation Proceedings. Elsevier Inc. 2015; 47 (9): 2737–2742.

17. Loor G et al. Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. The Lancet Respiratory Medicine. Elsevier Ltd. 2019; 7 (11): 975–984.

18. Martin JT, Zwischenberger JB. Artificial Lung and Novel Devices for Respiratory Support. Seminars in Thoracic and Cardiovascular Surgery. Elsevier Inc. 2013; 25(1): 70–75.

19. Tane S, Noda K, Shigemura N. Ex vivo Lung Perfusion: A Key Tool for Translational Science in the Lungs. Chest. Elsevier Inc. 2017; 151 (6): 1220–1228.

20. Ordies S et al. Prone Positioning During Ex vivo Lung Perfusion Influences Regional Edema Accumulation. Journal of Surgical Research. Elsevier Inc. 2019; 239(16): 300–308.

21. Lund LH et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report – 2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart and Lung Transplantation. Elsevier. 2016; 35(10): 1158–1169.

22. Cypel M et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. New England Journal of Medicine. 2011; 364 (15): 1431–1440.

23. Steen S, Sjöberg T, Pierre L, Liao Q. Leif Eriksson L.A.S. Transplantation of lungs from a non-heart-beating donor. 2005; 357: 1–5.